Malignant Hepatoblast‐Like Cells Sustain Stemness via IGF2‐Dependent Cholesterol Accumulation in Hepatoblastoma
Advanced Science · 2025
DOI: 10.1002/advs.202407671 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Miao Ding und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200120, P. R. Chin…. Hauptthemen laut MEDLINE: Hepatoblastoma, Insulin-Like Growth Factor II, Liver Neoplasms, Cholesterol. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Medical Innovation Research Special Project of Scientific and Technological Innovation Action Plan of Shanghai, Key project of Shanghai "Science and Technology Innovation Action Plan".
Abstract (Originalsprache)
Hepatoblastoma, the most aggressive childhood liver tumor, poses significant challenges due to limited knowledge of its pathogenesis, particularly in poorly differentiated advanced tumors where the prognosis is dismal. Single‐cell sequencing provides an in‐depth exploration at the single‐cell level and offers a deep understanding of tumor heterogeneity. Herein, single‐cell transcriptomics analysis is used to identify a unique malignant‐hepatoblast (HB)‐like cell subpopulation as the possible origin of poorly differentiated hepatoblastoma. These cells are associated with an unfavorable clinical prognosis in hepatoblastoma patients. The malignant‐HB‐like cell subpopulation generated insulin‐like growth factor 2 (IGF2) to sustain stem‐like features by promoting abnormal cholesterol accumulation via SREBF2. IGF2 also stimulated fibroblast 2 to secrete collagen 1, intensifying tumor malignancy via the collagen 1/integrin α1 signaling pathway. This suggests that targeting malignant HB‐like cells by inhibiting IGF2‐induced pathways can lead to promising treatments for hepatoblastoma. Additionally, serum IGF2 levels may serve as a diagnostic biomarker for advanced hepatoblastoma. In summary, these findings provide valuable insight into the genesis and malignancy of hepatoblastoma and a foundation for more effective diagnostic tools and therapeutic strategies for this challenging disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, 200120, P. R. China.
- Department Laboratory Medicine, Shanghai Tenth People's Hospital of Tongji University, Shanghai, 200072, P. R. China.
- Faculty of Medical Laboratory Science, College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai, 200000, P. R. China.
- Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics, Shanghai, 200120, P. R. China.
- Sanya Women and Children's Hospital Managed by Shanghai Children's Medical Center, Sanya, 572029, P. R. China.
- Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics, Shanghai, 200127, P. R. China.
ORCID-Profile: Miao Ding, Qiuhui Pan, Ji Ma
Förderung
- National Natural Science Foundation of China
- Medical Innovation Research Special Project of Scientific and Technological Innovation Action Plan of Shanghai
- Key project of Shanghai "Science and Technology Innovation Action Plan"
- Shanghai Key Laboratory of Clinical Molecular Diagnostics for Pediatrics
- Shanghai Education Development Foundation and Shanghai Municipal Education Commission
- Leading Talents in Health Care of Shanghai Municipal Health Commission
- Shanghai Municipal Health Commission
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Ding, M., Mao, S., Wu, H., Fang, S., Zhen, N., Chen, T., Zhu, J., Tang, X., Wang, X., Sun, F., Zhu, G., Pan, Q., & Ma, J. (2025). Malignant Hepatoblast‐Like Cells Sustain Stemness via IGF2‐Dependent Cholesterol Accumulation in Hepatoblastoma. Advanced Science. https://doi.org/10.1002/advs.202407671
Vancouver
Ding M, Mao S, Wu H, Fang S, Zhen N, Chen T, et al. Malignant Hepatoblast‐Like Cells Sustain Stemness via IGF2‐Dependent Cholesterol Accumulation in Hepatoblastoma. Advanced Science. 2025. doi:10.1002/advs.202407671
BibTeX
@article{Ding2025,
author = {Ding, Miao and Mao, Siwei and Wu, Han and Fang, Sijia and Zhen, Ni and Chen, Tianshu and Zhu, Jiabei and Tang, Xiaochen and Wang, Xiaoyang and Sun, Fenyong and Zhu, Guoqing and Pan, Qiuhui and Ma, Ji},
title = {Malignant Hepatoblast‐Like Cells Sustain Stemness via IGF2‐Dependent Cholesterol Accumulation in Hepatoblastoma},
journal = {Advanced Science},
year = {2025},
doi = {10.1002/advs.202407671}
}
EUVIMED